Plastic repair - component A

Hazard statements (CLP)

H315, H317, H319, H332, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture

Hazard categories

Category Hazard class and Hazard state- category ment 3.1I acute toxicity (inhal.) Acute Tox. 4 H332 3.2 skin corrosion/irritation Skin Irrit. 2 H315 3.3 serious eye damage/eye irritation Eye Irrit. 2 H319 3.4R respiratory sensitisation Resp. Sens. 1 H334 3.4S skin sensitisation Skin Sens. 1 H317 3.6 carcinogenicity Carc. 2 H351 3.8R specific target organ toxicity - single exposure (respiratory tract STOT SE 3 H335 irritation) 3.9 specific target organ toxicity - repeated exposure STOT RE 2 H373 For full text of H-phrases: see SECTION 16

Most important adverse effects

Delayed or immediate effects can be expected after short or long-term exposure

Signal word

Danger

Hazard pictograms

GHS07, GHS08

Hazard statements

H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H332 Harmful if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. H351 Suspected of causing cancer. H373 May cause damage to organs (respiratory system, respiratory tract) through prolonged or repeated exposure (if inhaled).

Precautionary statements

P201 Obtain special instructions before use. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312 Call a POISON CENTRE/doctor if you feel unwell. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P403+P233 Store in a well-ventilated place. Keep container tightly closed. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.

Contains

Isocyanic acid, polymethylenepolyphenylene ester; 4,4'-Methylenediphenyl diisocyanate, oligomers; Reaction mass of 4,4'-methylenediphenyl diisocyanate and o-(p-isocyanatobenzyl)phenyl isocyanate / methylene diphenyl diisocyanate; POLY- METHYLENEPOLYPHENYLENE ISOCYANATE-POLYPROPYLENE GLYCOL COPOLYMER; 4,4'-Methylenediphenyl diiso- cyanate, oligomeric reaction products with α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl).

2.3 Other hazards

Special danger of slipping by leaking/spilling product.

Results of PBT and vPvB assessment

Does not contain a PBT-/vPvB-substance at a concentration of ≥ 0,1%. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Category Hazard class and Hazard state- category ment 3.1I acute toxicity (inhal.) 4 Acute Tox. 4 H332 3.2 skin corrosion/irritation 2 Skin Irrit. 2 H315 3.3 serious eye damage/eye irritation 2 Eye Irrit. 2 H319 3.4R respiratory sensitisation 1 Resp. Sens. 1 H334 3.4S skin sensitisation 1 Skin Sens. 1 H317 3.6 carcinogenicity 2 Carc. 2 H351 3.8R specific target organ toxicity - single exposure (respiratory tract 3 STOT SE 3 H335 irritation) 3.9 specific target organ toxicity - repeated exposure 2 STOT RE 2 H373 For full text of H-phrases: see SECTION 16 The most important adverse physicochemical, human health and environmental effects Delayed or immediate effects can be expected after short or long-term exposure.